Skip to main content
OpenTrials

Clinical trial condition

Paraneoplastic Syndromes, Nervous System

Explore clinical trials studying Paraneoplastic Syndromes, Nervous System. Study availability and eligibility vary by location and protocol.

300 public trials 104 recruiting studies
Refine in advanced search Browse all conditions

Paraneoplastic Syndromes, Nervous System trial results

Completed

Safety and Tolerability of Rituximab in Neuromyelitis Optica

NCT00501748

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +21 more
Locations
  • UCSF MS Center , 350 Parnassus Ave , suite #908 San Francisco, California, United States
  • The Neurological Institute of New York MS Center Columbia University Medical Center 710 West 168th Street,, New York, United States
View Trial Details
Completed

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

NCT00683969

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Sun City, Arizona, United States
  • Sacramento, California, United States
  • Miami, Florida, United States
  • Kansas City, Kansas, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

NCT06282159

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Irvine, California, United States
  • Clinical Study Site Stamford, Connecticut, United States
  • Clinical Study Site Boca Raton, Florida, United States
View all 56 locations
View Trial Details
Active, Not Recruiting

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0011 41 Mobile, Alabama, United States
  • Mg0011 116 Phoenix, Arizona, United States
  • Mg0011 31 Irvine, California, United States
  • MG0011 4 Los Angeles, California, United States
View all 70 locations
View Trial Details

Related conditions